BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. 2012

Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.

A series of P1-substituted biaryl amprenavir derivatives was designed and synthesized. These compounds were evaluated for enzyme inhibition and antiviral activity in vitro. Several compounds showed highly efficient antiviral activity with EC(50) values down to 0.10nM, which are more potent than marketed HIV-1 protease inhibitors. Docking study indicated that 12c has similar binding mode to amprenavir with full occupancy in P1.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV

Related Publications

Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Study on Synthesis and Biological Evaluation of 3-Aryl Substituted Xanthone Derivatives as Novel and Potent Tyrosinase Inhibitors.
November 2019, Chemical & pharmaceutical bulletin,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Design, synthesis, and biological evaluation of novel 4-hydroxypyrone derivatives as HIV-1 protease inhibitors.
July 2005, Bioorganic & medicinal chemistry letters,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.
June 2009, Bioorganic & medicinal chemistry letters,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.
December 2002, Bioorganic & medicinal chemistry letters,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O-->N acyloxy migration of P1 moiety.
August 2003, Bioorganic & medicinal chemistry letters,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
January 2013, Bioorganic & medicinal chemistry letters,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
January 2015, Chemical & pharmaceutical bulletin,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors.
September 2012, Bioorganic & medicinal chemistry,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Synthesis and evaluation of potent human immunodeficiency virus 1 protease inhibitors with epimeric isopropanol as novel P1' ligands.
May 2020, Future medicinal chemistry,
Jianwei Yan, and Ning Huang, and Shukun Li, and Liu-Meng Yang, and Weiqiang Xing, and Yong-Tang Zheng, and Youhong Hu
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
June 2021, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!